
NanoMosaic
NanoMosaic interrogates biomolecules with nanoneedles at ultra-sensitive precision for diagnostics and AAV manufacturing.
- 30
- Company
- Waltham, MA, USUnited States

NanoMosaic interrogates biomolecules with nanoneedles at ultra-sensitive precision for diagnostics and AAV manufacturing.
nanomosaicllc.comCrawled Oct 29, 2026
NanoMosaic delivers ultra-sensitive multiomics powered by NanoNeedle technology — purpose-built for gene therapy analytics, neurology biomarkers, and brain health research. FDA/CBER AMT-designated AAV analytics platform.
NanoMosaic partners with a Mass General Brigham-led consortium to develop on-demand, distributed manufacturing for genetic medicines. The team secures up to **$39.2 million** from ARPA-H’s **GIVE program**, aiming to streamline cell and gene therapy production. The initiative is part of a broader **$125 million** ARPA-H funding effort across five selected teams. NanoMosaic contributes its expertise in multiomic analytical technologies to support scalable, decentralized manufacturing approaches.
Sep 2026PR NewswireNews article
Solid Biosciences and NanoMosaic partner to jointly market solutions for gene therapy delivery systems and analytics. The collaboration aims to provide developers with advanced tools for assessing empty, partial, and full delivery states. Together, they seek to enhance confidence in gene therapy research and clinical applications.
Jun 2026PR NewswireNews article
NanoMosaic receives an **Advanced Manufacturing Technology Designation** for its **Nanoneedle**, a tool supporting gene therapy production. The system aids in **upstream and downstream process development**, **quality control**, and **release testing** for biopharmaceutical manufacturers. Regulatory recognition may accelerate adoption in scalable gene therapy manufacturing.
Jan 2026GEN - Genetic Engineering and Biotechnology NewsNews article
NanoMosaic and Bristol-Myers Squibb (BMS) are collaborating to explore nanoneedle technology for advancing adeno-associated virus (AAV) manufacturing. The technology enables simultaneous quantification of full viral genomes and partial species, potentially improving production precision and quality control in gene therapy processes.
Feb 2025GEN - Genetic Engineering and Biotechnology NewsNews article